Arkolith/Insider Trading/KTRA/Form 4

Praill Anthony Scott

Chief Financial OfficerKintara Therapeutics, Inc. (KTRA) · full profile →Form 4 · filed Apr 29, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 29, 2021Other(J)8—$08K
Apr 29, 2021Conversion(C)938——8K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 29, 2021Conversion(C)4K—$00

Transaction Codes

J
Other acquisition / disposition
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905718-21-000630) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML